AGTC-501

· Beacon Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AGTC-501, covering 2024-08-12 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP [Phase 2, Phase 3]

See pricing